EnsoSleep
Overview
EnsoSleep is an FDA-cleared, AI-powered, cloud-based solution designed to simplify and accelerate the sleep testing, diagnosis, and treatment workflow for health systems, hospitals, and independent sleep labs. It provides a single platform for viewing, scoring, editing, and reporting of both in-lab Polysomnography (PSG) and Home Sleep Apnea Tests (HSATs).
The AI-assisted scoring automates event detection, including sleep staging, arousals, leg movements, and sleep-disordered breathing events like obstructive apneas, central apneas, and hypopneas. This automation significantly reduces the time sleep technologists and clinicians spend on manual scoring, with reported time savings averaging 62% for PSGs and 68% for HSATs.
EnsoSleep also includes features like EnsoHST™, which accelerates the analysis of photoplethysmogram (PPG) signals from pulse oximeters for sleep-disordered breathing, and the ability to produce accurate Total Sleep Time (TST) for HSAT devices that don’t inherently calculate it, improving diagnostic accuracy and potential reimbursements.
The platform is compatible with leading sleep medicine devices, offers seamless integrations, and prioritizes data confidentiality, availability, and integrity. It is built on a secure infrastructure that is HIPAA compliant and SOC 2 Type II Certified.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-assisted scoring for PSGs and HSATs
- Cloud-based study management platform
- Viewing, editing, and reporting of sleep studies
- Automated event detection (sleep staging, arousals, leg movements, SDB events)
- EnsoHSTu2122 for PPG signal analysis from pulse oximeters
- Accurate Total Sleep Time (TST) for HSATs
- Workflow automation and efficiency improvements
- Customizable reports and dynamic reporting
- Data import/export capabilities
- Third-party integrations and HL7 connectivity
Use Cases
- Accelerating diagnosis and treatment of sleep disorders
- Reducing manual sleep study scoring time for technologists
- Improving consistency and accuracy of sleep study scoring
- Expanding patient care capacity and outreach for sleep labs
- Optimizing sleep lab operations and workflow management
- Supporting diagnosis of sleep apnea and respiratory-related sleep disorders
What Physicians Need to Know
Leverage EnsoSleep's AI-powered scoring to significantly reduce manual review time for PSGs and HSATs, allowing more focus on patient education, complex cases, and treatment planning. Utilize the consistent and standardized AI scoring to enhance confidence in diagnostic results, especially for HSATs with the accurate Total Sleep Time (TST) feature. Take advantage of the cloud-based platform for flexible, remote access to studies and streamlined reporting, improving overall workflow efficiency and patient turnaround times. Remember that while the AI provides a highly accurate first pass, final diagnosis and treatment decisions remain the physician's responsibility after review and any necessary edits.
EnsoSleep is designed for seamless integration with a wide array of leading PSG and HSAT devices and existing sleep lab software platforms. It operates in the background, automating the initial scoring process and returning the AI-analyzed data to your native system. Additionally, it offers integration with ePrescribing platforms, such as Parachute Health, to further streamline the post-diagnosis treatment ordering workflow.
Details
| Category | Clinical Decision Support & Reference, Neurology AI |
| Pricing |
Starting at $9.50 per month
|
| Deployment | Cloud-based |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated EnsoSleep received its initial FDA 510(k) clearance in 2017 for diagnostic analysis of in-lab sleep studies in adults. It received expanded FDA 510(k) clearance (K210034) on June 8, 2021, to include scoring and analysis of home sleep studies, a browser-based viewing, editing, and reporting platform, and support for pediatric patients aged 13 and older, as well as detection of Cheyne-Stokes respiration and periodic breathing episodes. The latest FDA 510(k) clearance in February 2024 (EnsoSleep PPG) enables AI-driven analysis using photoplethysmogram (PPG) signals from FDA-cleared pulse oximeters. |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Pulmonology, Sleep Medicine |
What the Web Says
EnsoSleep is an FDA-cleared, AI-powered, cloud-based solution that automates the scoring and management of sleep studies, including both polysomnography (PSG) and home sleep apnea tests (HSATs). It aims to streamline workflows, reduce scoring times, and improve the consistency and accuracy of sleep study analysis for healthcare providers. The software is designed to be user-friendly for sleep technologists and physicians, allowing them to focus more on patient care and increasing testing volume.
Overall: PositiveStrengths
- Significantly decreases sleep study scoring times, often within 15 minutes.
- High accuracy in AI scoring, with reported 95% accuracy for pediatric event detection and 93% overall diagnostic AHI agreement for adults.
- Easy to use and integrates well with existing sleep systems and third-party data transfer systems.
- Improves consistency of staging and scoring, leading to increased physician satisfaction.
- Excellent customer service and responsive support team.
- Helps manage increased testing volume without needing additional staff, saving time and money.
Limitations
- Some users report the need to re-score tests after AI processing, particularly for respiratory events with artifact or for mixed apneas.
- Initial integration with EMR systems like EPIC has been reported as poor due to lack of coordination with internal IT departments.
- Software upgrades have occasionally corrupted event values.
- Cost for use has increased, impacting previous cost savings.
- The software is set to score based on one saved montage, and may not recognize changes to the initial sleep montage.
- Limited reviews available on platforms like G2 for comprehensive buying insight.
Based on reviews from: Capterra, Software Advice, G2, YouTube, Sleep Review, SoftwareWorld, EnsoData, Philadelphia Sleep Conference
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate EnsoSleep
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for EnsoSleep.
EnsoSleep AI Scoring Demo and Overview
Frequently Asked Questions
Investors who backed EnsoSleep
Funded through the company that built this tool.
